Catalyst Pharmaceuticals to Present at the Jefferies 2017 Healthcare Conference
Jun 01, 2017 12:39 pm UTC| Business
CORAL GABLES, Fla., June 01, 2017 -- Catalyst Pharmaceuticals, Inc.(Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases,...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...